A murine monoclonal anti-DNA antibody (PME77) has been found to bind tightly to the plasma membrane of Raji cells. We show here that this monoclonal anti-DNA antibody reacts in a radjoimmunoassay with the cell surface of a variety of mammalian cell types and that the antigenic determinant recognized by the monoclonal anti-DNA antibody at the surface of Raji cells is resistant to DNase. It belongs to polypeptides removed from the cell surface by a mild proteinase K treatment.
Most of the tissue lesions observed in murine and human systemic lupus erythematosus (SLE) are considered to be due to the presence of anti-double-stranded DNA antibodies spontaneously produced in this disease (1) , but paradoxically it is extremely difficult to produce antibodies to doublestranded DNA by immunization (2) .
We recently reported that a murine anti-DNA monoclonal antibody (mAb) reacted with the surface of Raji cells and that the binding was not abrogated by DNase treatment of the cells (3) . We show here that (i) this mAb does indeed react with the surface of a variety of mammalian cell types and (ii) the determinant detected by this mAb at the surface of Raji cells belongs to polypeptides removed from the cell surface by a mild proteinase K treatment.
MATERIALS AND METHODS
Lymphoblastoid B-Cell Lines. The Raji lymphoblastoid cell line was obtained and maintained as described (3) . The human Ramos B-cell line was derived from a B-lymphoma line. The human HSB2 T-cell line was derived from an acute lymphocytic T-cell leukemia.
Cell lines were maintained in suspension culture in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum/penicillin (100 units/ml)/streptomycin (100 ug/ ml), all from GIBCO.
Human Tissue. Neuroblastoma cells were obtained from Flow Laboratories and maintained in suspension culture in Hanks' medium (Flow Laboratories) supplemented with 10% fetal calf serum.
Preparation of Peripheral Blood Lymphocytes. Heparinized peripheral blood was obtained from healthy adult donors. Mononuclear cells were separated by centrifugation on Ficoll-Paque (Pharmacia) as described (4) . Non-adherent cells were washed twice in Hanks' balanced salt solution and separated into E+ and E-subpopulations by rosetting 2 times with sheep erythrocytes. The E+ cells were liberated from the sheep erythrocytes by hypotonic lysis (5) . Viability, assessed by trypan blue dye exclusion, was at least 95%.
Preparation of Human Erythrocytes. Erythrocytes were separated from mononuclear cells by centrifugation on Ficoll-Paque as described (4) .
All cell types were used at a concentration of 0.5-1 x 107 cells per ml.
Murine mAb. The hybridoma PME77 secreting anti-DNA antibody was isolated after fusion between a nonsecrgfing myeloma line (P3 x 63-Ag 8653) and (NZB x NZW) Fl spleen cells. The selection of hybrid, cloning and subcloning of the line, purification of the antibody, characterization of its class and subclass, and its specificity study have all been described in detail (6, 7) . PME77 mAb was shown to be an IgG2b, K-chain antibody and sharply specific for DNA (7 The amount of radioactivity bound to the cell pellet was quantified in a gamma scintillation counter. All determinations were done in duplicate. PME77 Fab Fragments. Fab fragments were prepared as described (3) . Briefly, Fab fragments of PME77 mAb were prepared by digestion with mercuripapain (Sigma) (Ab/enzyme ratio, 100:1) (8). The digestion was in 10 mM EDTA/10 mM cysteine/phosphate-buffered saline (Pi/NaCI), pH 7.2.
The digestion was terminated after 2 hr by dialysis in 0.005 M phosphate (pH 8). The digest was passed through a DEAE cellulose column (Whatman) and the Fab fragments were isolated as the first peak by gradient elution in phosphate buffer from 5 mM to 500 mM. The DNA-binding capacity of the Fab fragments was checked in a cellulose ester filter radioimmunoassay (9) . Fab fragments were incubated with Raji cells as described above. Cells were washed free of unbound material and incubated with a rabbit anti-mouse K light chain (Litton Bionetics) radioiodinated by the chloramine-T method (specific activity, 106 cpm/lgg. 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. NaDodSO4/polyacrylamide slab gels were run according to Laemmli (12) . After electrophoresis, the immunoreplica technique was carried out as described by Burnette (13) and modified by Coudrier et al. (14) . After electrotransfer of polypeptides, the nitrocellulose sheet was incubated with the supernatant of PME77 mAb-secreting hybridoma for 90 min at room temperature. The antigen-PME77 mAb complexes were detected with the peroxidase technique. Molecular weight markers were as follows: phosphorylase b (93,000), bovine serum albumin (66,000), ovalbumin (43,000), carbonic anhydrase (30,000), trypsin inhibitor (20,000), and lactalbumin (14,000). The (3) . Similarly, cell-binding experiments, using 125I-labeled protein A as a tracer, demonstrated that PME77 mAb binds to a number of other human cell types: human erythrocytes, neuroblastoma, a T-lymphoblastoid cell line (HSB2), a B-lymphoblastoid cell line (Ramos), and normal T and B lymphocytes (Table 1) . PME77 Fab fragments were shown to react with these cell types, using 1251-labeled rabbit anti-K light chain as the tracer (Table   Table 2 Immunorepliva Analysis. After electrotransfer of polypeptides to the nitrocellulose sheet, the supernatant of PME77 mAb was added and incubated. As shown in Fig. 1 , five bands could be detected at Mrs 14,000, 16,000, 17,000, 33,000, and 34,000; four of these bands showed a strong reactiop and the fifth showed a weaker one. The same pattern was observed when unreduced samples were used in a similar experiment. Two controls were used: (i) When PME77 mAb was preincubated with DNA (1 mg/ml), the staining of all bands was strongly decreased (Fig. 1). (ii) Using a DNA unrelated mAb; for this purpose, a mAb raised against a minor membrane protein of the Golgi apparatus was applied to the nitrocellulose sheets (15) . No band appeared under these conditions (Fig. 1) .
Immunoreplica Patterns of Raji Cells Untreated or Treated with Proteinase K. The comparison of immunoreplica patterns of Raji cells untreated or treated with proteinase K was studied to determine which of the polypeptide(s) recognized by PME77 mAb is accessible at the cell surface. A mild proteinase K treatment that does not alter cell viability is an assay that probes for a portion of membrane protein(s) accessible at the cell surface. When Raji cells were pretreated with proteinase K at 100 ,g/ml (>95% living cells), two of the five bands (Mrs, 33,000 and 34,000) were almost completely removed; the band at Mr 16,000 was decreased. In contrast, one band remained unchanged (Mr, 17,000). This suggests that the Mr 17,000 polypeptide is either resistant to proteinase K or it lies inside the cell.
DISCUSSION
As long as the predominant autoantibodies in murine and human SLE were considered to be directed exclusively against DNA, it appeared difficult to understand how the production of these antibodies could be triggered. The recognition by anti-DNA mAb of phospholipids provided the first evidence of a possible triggering mechanism (16) . Here, we show that a mAb with strict specificity for double-stranded DNA (4) binds to various mammalian cell types and recognizes a few (five) polypeptides. Three of these polypeptides appear to be sensitive to proteinase K action and, therefore, are expressed at the cell surface.
The nature of the antigenic determinant common to DNA and the polypeptides and whether the epitope(s) detected at the Raji cell surface by PME77 mAb are identical to those present at the surface of the other human cell types shown to bind PME77 remain to be determined. The affinity of the anti-DNA mAb for protein(s) that we have shown might acWe wish to thank Marie-Annick Lety and Beatrice Legrand for their excellent technical assistance. This work was supported by Institut National de la Sante et de la Recherche Mddicale Grant 811050 (to L.J.).
